Carcinoma in situ of skin of lip
ICD-10 D04.0 is a billable code used to indicate a diagnosis of carcinoma in situ of skin of lip.
Carcinoma in situ of the skin of the lip refers to a localized, non-invasive form of cancer that is confined to the epithelial layer of the lip. This condition is characterized by the abnormal proliferation of keratinocytes, which can lead to the development of squamous cell carcinoma if left untreated. Clinically, it may present as a persistent sore, ulcer, or lesion on the lip that does not heal. Risk factors include excessive sun exposure, tobacco use, and a history of actinic keratosis. Diagnosis is typically confirmed through a biopsy, which reveals atypical keratinocytes confined to the epidermis. Treatment options may include surgical excision, cryotherapy, or topical chemotherapy. Regular surveillance is crucial, as carcinoma in situ can progress to invasive cancer if not monitored and managed appropriately. Patients are advised to undergo periodic skin examinations and to practice sun protection to mitigate further risk.
Detailed descriptions of lesions, biopsy results, and treatment plans.
Diagnosis and management of suspicious lip lesions, follow-up after treatment.
Ensure accurate documentation of lesion characteristics and treatment response.
Comprehensive treatment history, including surgical and non-surgical interventions.
Management of patients with a history of skin cancers, surveillance protocols.
Documenting the patient's risk factors and treatment outcomes is crucial for coding.
Used when excising a carcinoma in situ lesion on the lip.
Document the size of the lesion and the excised diameter.
Ensure the procedure is documented in the context of the diagnosis.
Carcinoma in situ of the lip is a pre-cancerous condition that requires monitoring and potential treatment to prevent progression to invasive cancer.
